Top

Published in:

01-06-2021 | Original Article

Validation of Global Limb Anatomical Staging System (GLASS) in patients with hemodialysis and Chronic Limb-Threatening Ischemia after endovascular treatment

Authors: Takahiro Tokuda, Yasuhiro Oba, Ryoji Koshida, Ai Kagase, Hiroaki Matsuda, Yoriyasu Suzuki, Akira Murata, Tatsuya Ito

Published in: Heart and Vessels | Issue 6/2021

Abstract

Recently, Society for Vascular Surgery guideline recommends evaluating anatomic pattern with use of Global Limb Anatomic Staging System (GLASS) in Chronic Limb-Threatening Ischemia (CLTI) patients. The aim of this study is to validate GLASS stage into CLTI patients on hemodialysis (HD) and investigate the impact of GLASS stage to wound healing and amputation-free survival (AFS). Between April 2009 and March 2018, we performed EVT for 154 limbs in CLTI patients on HD. GLASS was defined as femoropopliteal (FP) and infrapopliteal (IP) segments separately graded (0–4), then combined into three GLASS stages for the limb (I–III). We divided them into three GLASS stages with using this system. We compared the clinical outcomes between three groups (GLASS I, GLASS II, and GLASS III). Patient characteristics were almost similar between the three groups. Lesion characteristics was more complex and the rate of success was lower in GLASS III. Cox regression multivariate analysis revealed that diabetes mellitus (HR 2.4, 95% CI 1.37–4.01, p < 0.01) and WIfI high (HR 2.3, 95% CI 1.04–6.01, p = 0.04) were the predictors of non-wound healing, whereas age (HR 1.6, 95% CI 1.09–2.29, p = 0.01), WIfI clinical stage 4 (HR 2.4, 95% CI 1.30–4.36, p < 0.01), and non-ambulatory status (HR 2.0, 95% CI 1.17–3.29, p = 0.01) were the predictors of AFS. GLASS stage in CLTI patient on HD could not predict wound healing, and AFS in this study.

Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, Aboyans V, Aksoy M, Alexandrescu VA, Armstrong D, Azuma N, Belch J, Bergoeing M, Bjorck M, Chakfé N, Cheng S, Dawson J, Debus ES, Dueck A, Duval S, Eckstein HH, Ferraresi R, Gambhir R, Gargiulo M, Geraghty P, Goode S, Gray B, Guo W, Gupta PC, Hinchliffe R, Jetty P, Komori K, Lavery L, Liang W, Lookstein R, Menard M, Misra S, Miyata T, Moneta G, Munoa Prado JA, Munoz A, Paolini JE, Patel M, Pomposelli F, Powell R, Robless P, Rogers L, Schanzer A, Schneider P, Taylor S, De Ceniga MV, Veller M, Vermassen F, Wang J, Wang S (2019) Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg 58(1S):S1-S109.e33

Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1(2):219–227PubMed

Van Dongen IM, Elias J, García-García HM, Hoebers LP, Ouweneel DM, Scheunhage EM, Delewi R, Råmunddal T, Eriksen E, Claessen BE, van der Schaaf RJ, Henriques JPS (2019) Value of the SYNTAX score in ST-elevation myocardial infarction patients with a concomitant chronic total coronary occlusion(from the EXPLORE Trial). Am J Cardiol 123(7):1035–1043CrossRef

Yang H, Zhang L, Xu CH (2019) Use of the SYNTAX Score II to predict mortality in interventional cardiology: a systematic review and meta-analysis. Medicine (Baltimore) 98(2):e14043CrossRef

Fujino A, Kadohira T, Redfors B, Maehara A, Serruys PW, Mintz GS, Gregg WS, Philippe G (2019) Significant association among residual SYNTAX score, non-culprit major adverse cardiac events, and greyscale and virtual histology intravascular ultrasound findings: a substudy from the PROSPECT study. EuroIntervention 14(16):1676–1684CrossRef

Esper RB, Farkouh ME, Ribeiro EE, Hueb W, Domanski M, Hamza TH, Flora SS, Lucas Colombo G, Verghese M, John F, Valentin F (2018) SYNTAX Score in patients with diabetes undergoing coronary revascularization in the FREEDOM trial. J Am Coll Cardiol 72(23 Pt A):2826–2837CrossRef

Yoon YH, Ahn JM, Kang DY, Park H, Cho SC, Lee PH, Seung-Whan L, Seong-Wook P, Duk-Woo P, Seung-Jung P (2020) Impact of SYNTAX score on 10-year outcomes after revascularization for left main coronary artery disease. JACC Cardiovasc Interv 13(3):361–371CrossRef

Yan L, Li P, Wang Y, Han D, Li S, Zhang J, Min J, Li F, Yaling H, Feng C (2020) Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency. Catheter Cardiovasc Interv 95(Suppl 1):606–615CrossRef

Modolo R, Chichareon P, van Klaveren D, Dressler O, Zhang Y, Sabik JF, Yoshinobu O, Arie Pieter K, Gregg WS, Patrick WS (2020) Impact of non-respect of SYNTAX score II recommendation for surgery in patients with left main coronary artery disease treated by percutaneous coronary intervention: an EXCEL substudy. Eur J Cardiothorac Surg 57(4):676–683PubMed

10.

Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T, Hamano T, Wakai K, Wada A, Nitta K (2015) An overview of regular dialysis treatment in Japan (As of 31 December 2013). Ther Apher Dial 19:540–574CrossRef

11.

Yamamoto S, Hosaka A, Okamoto H, Shigematsu K, Miyata T, Watanabe T (2014) Efficacy of revascularization for critical limb ischemia in patients with end-stage renal disease. Eur J Vasc Endovasc Surg 48:316–324CrossRef

12.

Kodama A, Sugimoto M, Kuma S, Okazaki J, Mii S, Komori K (2014) Clinical outcomes after infrainguinal bypass grafting for critical limb ischemia in patients with dialysis-dependent end-stage renal failure. Eur J Vasc Endovasc Surg 48:695–702CrossRef

13.

Nakano M, Hirano K, Iida O, Soga Y, Kawasaki D, Suzuki K, Suzuki K, Miyashita Y (2013) Prognosis of critical limb ischemia in hemodialysis patients after isolated infrapopliteal balloon angioplasty: results from the Japan Below-the-Knee Artery Treatment (J-BEAT) Registry. J Endovasc Ther 20:113–124CrossRef

14.

Azuma N, Uchida H, Kokubo T, Koya A, Akasaka N, Sasajima T (2012) Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery? Eur J Vasc Endovasc Surg 43:322–328CrossRef

15.

Iida O, Nakamura M, Yamauchi Y, Kawasaki D, Yokoi Y, Yokoi H, Soga Y, Zen K, Suematsu N, Inoue N, Suzuki K, Hirano K, Shintani Y, Miyashita Y, Urasawa K, Kitano I, Tsuchiya T, Kawamoto K, Yamaoka T, Uesugi M, Shinke T, Oba Y, Ohura N, Uematsu M, Takahara M, Hamasaki T, Nanto S (2013) Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up. Circ Cardiovasc Interv 6(1):68–76CrossRef

16.

Hoshina K, Yamamoto K, Miyata T, Watanabe T (2016) Outcomes of critical limb ischemia in hemodialysis patients after distal bypass surgery—poor limb prognosis with stage 4 wound, ischemia, and foot infection (WIfI). Circ J 80(11):2382–2387CrossRef

17.

Rao A, Baldwin M, Cornwall J, Marin M, Faries P, Vouyouka A (2017) Contemporary outcomes of surgical revascularization of the lower extremity in patients on dialysis. J Vasc Surg 66(1):167–177CrossRef

18.

Tokuda T, Hirano K, Sakamoto Y, Mori S, Kobayashi N, Araki M, Yamawaki M, Ito Y (2018) Use of the Wound, Ischemia, foot Infection classification system in hemodialysis patients after endovascular treatment for critical limb ischemia. J Vasc Surg 67(6):1762–1768CrossRef

19.

Hata Y, Iida O, Takahara M, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Matsuda Y, Mano T (2020) Infrapopliteal anatomic severity and delayed wound healing in patients with chronic limb-threatening ischemia in the era of the global limb anatomic staging system. J Endovasc Ther 27(4):641–646CrossRef

20.

Tokuda T, Oba Y, Koshida R, Suzuki Y, Murata A, Ito T (2020) Prediction of the technical success of endovascular therapy in patients with critical limb threatening ischaemia using the global limb anatomical staging system. Eur J Vasc Endovasc Surg. https://doi.org/10.1016/j.ejvs.2020.05.003CrossRefPubMed

21.

Sumpio BE, Forsythe RO, Ziegler KR, van Baal JG, Lepantalo MJ, Hinchliffe RJ (2013) Clinical implications of the angiosome model in peripheral vascular disease. J Vasc Surg 58:814–826CrossRef

22.

Kobayashi N, Hirano K, Yamawaki M, Araki M, Takimura H, Sakamoto Y, Mori S, Ito Y (2017) Clinical effects of single or double tibial artery revascularization in critical limb ischemia patients with tissue loss. J Vasc Surg 65(3):744–753CrossRef

23.

Mills JL, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, Andros G (2014) The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 59:220–234CrossRef

24.

Viera AJ, Garrett JM (2005) Understanding interobserver agreement: the kappa statistic. Fam Med 37:360–363PubMed

25.

Tokuda T, Hirano K, Sakamoto Y, Takimura H, Kobayashi N, Araki M, Yamawaki M, Ito Y (2017) Incidence and clinical outcomes of the slow-flow phenomenon after infrapopliteal balloon angioplasty. J Vasc Surg 65(4):1047–1054CrossRef

26.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Volkmar F, José Ramón GJ, Veli-Pekka H, Ewa AJ, Mariell J, Cecilia L, Petros N, John TP, Burkert P, Jillian PR, Giuseppe MCR, Luis MR, Frank R, Frans HR, van der Peter M, ESC Scientific Document Group (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRef

27.

Ohtake T, Oka M, Ikee R, Mochida Y, Ishioka K, Moriya H, Moriya H, Hidaka S, Kobayashi S (2011) Impact of lower limbs’ arterial calcification on the prevalence and severity of PAD in patients on hemodialysis. J Vasc Surg 53(3):676–683CrossRef

Title: Validation of Global Limb Anatomical Staging System (GLASS) in patients with hemodialysis and Chronic Limb-Threatening Ischemia after endovascular treatment
Authors: Takahiro Tokuda
Yasuhiro Oba
Ryoji Koshida
Ai Kagase
Hiroaki Matsuda
Yoriyasu Suzuki
Akira Murata
Tatsuya Ito
Publication date: 01-06-2021
Publisher: Springer Japan
Published in: Heart and Vessels / Issue 6/2021
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI: https://doi.org/10.1007/s00380-020-01747-1

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Validation of Global Limb Anatomical Staging System (GLASS) in patients with hemodialysis and Chronic Limb-Threatening Ischemia after endovascular treatment

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2021

Investigating the cause of hemolysis in patients supported by a pulsatile ventricular assist device

Assessment of visit-to-visit variability in systolic blood pressure over 5 years and phasic left atrial function by two-dimensional speckle-tracking echocardiography

Clinical effectiveness and adverse events associated with tolvaptan in patients above 90 years of age with acute decompensated heart failure

Electrocardiographic features of arrhythmogenic right ventricular cardiomyopathy in school-aged children

Evolution of patients with chronic thromboembolic pulmonary hypertension treated by balloon pulmonary angioplasty, according to their anticoagulant regimens

Safe and effective transvenous lead extraction for elderly patients utilizing non-laser and laser tools: a single-center experience in Japan

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page